Page 1447 - Problem-Based Feline Medicine
P. 1447
1440 INDEX
Hormonal dysfunction, 1147–1148 diagnosis, 74–75 pathogenesis, 245–247
Hormones, spraying, 1012 location, 71, 74 polyuria/polydipsia, 245–250
Horner’s syndrome, 843, 875–876, mechanism, 71, 73–74 prevention, 250
931, 1335–1337 see also specific diseases/disorders prognosis, 250
clinical signs, 876, 1336 Hydroxycoumarins, 507 treatment, 249–250, 684
diagnosis, 876, 1336 Hydroxyethyl starch, dehydration, 559 vomiting, acute, 631, 652–653
differential diagnosis, 876, 1336 Hydroxyurea, 1375 vomiting, chronic, 664, 683–684
miosis, 871, 875–876 hypereosinophilic syndrome, 729, Hypercholesterolemia, 359, 572
pathogenesis, 875–876, 1335–1336 759 Hyperchylomicronemia, inherited, 570,
prognosis, 876, 1337 polycythemia vera, 564 575–576
third eyelid neuropathy, 1332, Hydroxyzine, 1376 Hypercontractile bladder, 174,
1335–1337 Hyperacidity, gastric ulcer association, 190–191
treatment, 876, 1336–1337 637 Hyperemia, 1208, 1211
Horns, cutaneous, 1108, 1122–1123 Hyperadrenocorticism, 62, 232, Hypereosinophilic syndrome, 394, 416,
Hot weather, 294–295 251–252, 324–326, 470, 520, 729, 758–759
Household cleaner ingestion, 580, 1063–1064, 1121–1122 clinical signs, 729, 759
587–588 abdominal distention/fluid, 444, 470 diagnosis, 729, 759
Houseplant ingestion, 1019 alopecia, 1053, 1063–1064 diarrhea, acute small bowel, 700,
House-soiling problems, urine, 221 clinical signs, 255, 259, 302, 324, 729
Housing, infertility and, 1149, 1150, 470, 520, 1063, 1121 diarrhea, chronic small bowel, 737,
1151 diabetes mellitus, 236 758–759
Human recombinant alpha interferon, diagnosis, 324–325, 470, differential diagnosis, 759
342 1063–1064, 1122 lymphadenopathy, 416
Human recombinant erythropoietin, diarrhea, chronic small bowel, 735 pathogenesis, 758–759
540 differential diagnosis, 325, 470, prognosis, 729, 759
Hyaluronate, 1375 1064 treatment, 729, 759
Hyaluronidase, 950 hemorrhage, 482, 520 Hyperesthesia syndrome, 862–863
Hycodan, 1375 imaging, 325 clinical signs, 862, 1016, 1017
Hydralazine, 1375 obesity, 453 diagnosis, 862–863
Hydration maintenance, renal failure, pathogenesis, 324 differential diagnosis, 863
336 paw/pad problems, 1108, 1121–1122 pathogenesis, 862, 1016
Hydrocephalus, 826–828, 932–933 pituitary-dependent, 325, 326 prevention, 863
acquired, 933 polyuria/polydipsia, 251–252 treatment, 863
ataxia, 932–933 prevention, 326 tremor/twitching, fine
clinical signs, 827, 925, 932–933 prognosis, 326 (unintentional), 854, 862–863
congenital, 805, 825, 933 treatment, 325–326, 470, 1064 Hypergastrinemia, 339
diagnosis, 827, 933 weight loss with good appetite, Hyperglycemia
differential diagnosis, 827–828, 833, 324–326 diabetes mellitus, 237, 311–312
884 Hyperaldosteronism (Conn’s diabetic ketoacidosis, 292
pathogenesis, 826–827 syndrome), 232, 256–257 sepsis, acute, 971
stupor/coma, 821, 826–828 hypokalemic myopathy, 893–894 stress induced, 311–312
treatment, 828 primary, 256–257 Hyperkalemia
Hydrochlorothiazide, 131, 137, 152, Hyperbilirubinuria see Icterus acute renal failure complication,
1375 Hypercalcemia, 184, 233, 245–250, 281–282
Hydrocortisone, 1375 652–653, 683–684 atrial standstill, 168
allergic conjunctivitis, 1222 chronic renal failure, 235 sepsis, acute, 971
Hydrodistension, lower urinary tract clinical signs, 247–248, 652, 683–684 treatment, 282
disease, 178 diagnosis, 248, 652–653, 684 Hyperkinetic left ventricle, 155
Hydrogen peroxide, emesis induction, differential diagnosis, 248–249 Hyperlipidemia, 569–577, 968–969
286, 1375 idiopathic, 247, 248, 684 causes, 570, 572, 573–577
Hydrothorax, 71–89 malignancy, of, 246, 652–653, 684 clinical signs, 570, 573, 574, 942,
causes/diseases causing, 71, 72–73, parathyroid hormone elevation in 968
74, 75–89 chronic renal failure, 338 definition, 570